Short answer · Medically reviewed summary · Last updated: 2026-04-07
Alpha 1-antitrypsin deficiency is a genetic condition caused by mutations in the SERPINA1 gene, which prevent the liver from producing enough functional alpha-1 antitrypsin protein to protect the lungs and liver from damage. Because this protein acts as a "shield" against enzymes that break down tissue, its absence or dysfunction leads to the progressive destruction of lung air sacs and potential liver inflammation. What causes Alpha 1-antitrypsin deficiency? The primary cause of Alpha 1-antitrypsin deficiency is an inherited genetic mutation.
2 people with Alpha 1-antitrypsin deficiency have shared their first-person experience on this question at DiseaseMaps.
Alpha 1-antitrypsin deficiency is a genetic condition caused by mutations in the SERPINA1 gene, which prevent the liver from producing enough functional alpha-1 antitrypsin protein to protect the lungs and liver from damage. Because this protein acts as a "shield" against enzymes that break down tissue, its absence or dysfunction leads to the progressive destruction of lung air sacs and potential liver inflammation.
The primary cause of Alpha 1-antitrypsin deficiency is an inherited genetic mutation. In a healthy individual, the SERPINA1 gene provides instructions for making the alpha-1 antitrypsin (AAT) protein. This protein is produced in the liver and released into the bloodstream, where it travels to the lungs to neutralize an enzyme called neutrophil elastase. Think of AAT as a protective bodyguard; without it, the neutrophil elastase—which is supposed to help fight infections—begins to "chew" through healthy lung tissue, leading to emphysema and chronic obstructive pulmonary disease (COPD).
Yes, Alpha 1-antitrypsin deficiency is an autosomal codominant genetic disorder. This means that a person inherits one copy of the SERPINA1 gene from each parent. If both parents pass on a mutated gene (often called the "Z" allele), the child will likely develop a severe form of the condition. Clinical geneticists categorize the severity based on these alleles; for instance, individuals with the "PiZZ" genotype typically have the lowest levels of protective protein, making them significantly more vulnerable to lung and liver disease.
While the root cause is genetic, environmental factors act as major "triggers" that accelerate the progression of Alpha 1-antitrypsin deficiency. The most significant risk factor is cigarette smoke. Smoking introduces toxins that further inflame the lungs, effectively overwhelming the already depleted supply of AAT proteins. Other environmental risk factors include:
While we fully understand the genetic basis of Alpha 1-antitrypsin deficiency, research is ongoing regarding the "gain-of-function" toxicity in the liver. In the most common severe form (the Z-mutation), the AAT protein is misfolded. Instead of being released into the blood, it gets stuck inside the liver cells like a "clogged pipe." Scientists are currently researching ways to prevent this protein clumping in the liver while simultaneously finding better ways to replace the missing protein in the lungs. With 339 members in the DiseaseMaps community sharing their personal journeys, it is clear that understanding these mechanisms is vital to improving quality of life and developing targeted gene therapies.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.